176. The tumor necrosis factor-alpha antagonist infliximab reduces depressive symptoms in patients with treatment resistant depression and high inflammation
2018 ◽
Vol 235
◽
pp. 250-256
◽
2010 ◽
Vol 16
(6)
◽
pp. 274-279
◽
2012 ◽
Vol 125
(6)
◽
pp. e9-e10
◽
2012 ◽
Vol 18
(7)
◽
pp. 670-676
◽
2007 ◽
Vol 14
(4)
◽
pp. 412
◽
2013 ◽
Vol 116
(6)
◽
pp. e503-e504